Baird Financial Group, Inc. - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 242 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$634,106
+34.0%
23,274
+6.6%
0.00%
+100.0%
Q1 2023$473,076
+136233.1%
21,841
+28.0%
0.00%0.0%
Q4 2022$347
-99.9%
17,068
+81.2%
0.00%0.0%
Q3 2022$241,000
-86.7%
9,417
-92.6%
0.00%
-85.7%
Q3 2019$1,807,000
+10.3%
127,828
-13.0%
0.01%
+16.7%
Q2 2019$1,638,000146,9360.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders